Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8521)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2017 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zeng JF, Ma XQ, Wang LP, Wang W. MicroRNA-145 exerts tumor-suppressive and chemo-resistance lowering effects by targeting CD44 in gastric cancer. World J Gastroenterol 2017; 23(13): 2337-2345 [PMID: 28428713 DOI: 10.3748/wjg.v23.i13.2337] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i13/2337.htm |
| Number | Citing Articles |
| 1 |
Bo Sun, Haiyuan Sun, Qunying Wang, Xinhong Wang, Jingzi Quan, Dongfang Dong, Yue Lun. Circular RNA circMAN2B2 promotes growth and migration of gastric cancer cells by down‐regulation of miR‐145. Journal of Clinical Laboratory Analysis 2020; 34(6) doi: 10.1002/jcla.23215
|
| 2 |
Priya Mondal, Syed Musthapa Meeran. microRNAs in cancer chemoresistance: The sword and the shield. Non-coding RNA Research 2021; 6(4): 200 doi: 10.1016/j.ncrna.2021.12.001
|
| 3 |
Rui-Peng Zheng, Dong-Kai Ma, Zhuo Li, Hai-Feng Zhang. <p>MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4</p>. Cancer Management and Research 2020; : 6165 doi: 10.2147/CMAR.S257598
|
| 4 |
Xudong Dai, Yong Chen, Ning Chen, Jin Dou, Haiwen Zhuang, Jian Wang, Xin Zhao, Xiaoyu Zhang, Haijian Zhao. KLF5-mediated aquaporin 3 activated autophagy to facilitate cisplatin resistance of gastric cancer. Immunopharmacology and Immunotoxicology 2023; 45(2): 140 doi: 10.1080/08923973.2022.2122498
|
| 5 |
Marianna Nalli, Michela Puxeddu, Giuseppe La Regina, Stefano Gianni, Romano Silvestri. Emerging Therapeutic Agents for Colorectal Cancer. Molecules 2021; 26(24): 7463 doi: 10.3390/molecules26247463
|
| 6 |
Peng Ye, Yu Shi, Nairui An, Qian Zhou, Juan Guo, Xinghua Long. miR-145 overexpression triggers alteration of the whole transcriptome and inhibits breast cancer development. Biomedicine & Pharmacotherapy 2018; 100: 72 doi: 10.1016/j.biopha.2018.01.167
|
| 7 |
Arash Poursheikhani, Zahra Bahmanpour, Ehsan Razmara, Ladan Mashouri, Mohammad Taheri, Dorsa Morshedi Rad, Hassan Yousefi, Amirreza Bitaraf, Sadegh Babashah. Non-coding RNAs underlying chemoresistance in gastric cancer. Cellular Oncology 2020; 43(6): 961 doi: 10.1007/s13402-020-00528-2
|
| 8 |
Xi Zeng, Hao-Ying Wang, Su-Yang Bai, Ke Pu, Yu-Ping Wang, Yong-Ning Zhou. The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer. Current Molecular Medicine 2021; 20(9): 667 doi: 10.2174/1566524020666200226124336
|
| 9 |
Kangqi Yang, Tuo Yi. Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy. Frontiers in Molecular Biosciences 2024; 10 doi: 10.3389/fmolb.2023.1297611
|
| 10 |
Ying Liu, Xiang Ao, Guoqiang Ji, Yuan Zhang, Wanpeng Yu, Jianxun Wang. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.768918
|
| 11 |
An Yang, Xin Liu, Ping Liu, Yunzhang Feng, Hongbo Liu, Shen Gao, Limin Huo, Xinyan Han, Jurong Wang, Wei Kong. LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis. Cellular & Molecular Biology Letters 2021; 26(1) doi: 10.1186/s11658-021-00275-8
|
| 12 |
Wei-Qiang Yang, Wei-Jun Zhao, Liu-Lian Zhu, Shuai-Jun Xu, Xue-Lin Zhang, Yong Liang, Xiao-Fei Ding, Alexander Kiselyov, Guang Chen. XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.603453
|
| 13 |
Malak Hassn Mesrati, Saiful Effendi Syafruddin, M. Aiman Mohtar, Amir Syahir. CD44: A Multifunctional Mediator of Cancer Progression. Biomolecules 2021; 11(12): 1850 doi: 10.3390/biom11121850
|
| 14 |
Xiaoli Liu, Yifei Wang, Bonan Chen, Wai Nok Chan, Chun Wai Mui, Alvin H.K. Cheung, Jinglin Zhang, Kit Yee Wong, Jun Yu, Wei Kang, Ka Fai To. Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside. Biomedicines 2022; 10(10): 2512 doi: 10.3390/biomedicines10102512
|
| 15 |
Li-Li Mei, Wen-Jun Wang, Yun-Tan Qiu, Xiu-Feng Xie, Jie Bai, Zhi-Zhou Shi. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma. International Journal of Molecular Sciences 2017; 18(9): 1833 doi: 10.3390/ijms18091833
|
| 16 |
Dharambir Kashyap, Hardeep Singh Tuli, Vivek Kumar Garg, Neelam Goel, Anupam Bishayee. Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential. Molecular Diagnosis & Therapy 2018; 22(2): 179 doi: 10.1007/s40291-018-0316-1
|
| 17 |
Masataka Shimonosono, Tetsuya Idichi, Naohiko Seki, Yasutaka Yamada, Takayuki Arai, Takaaki Arigami, Ken Sasaki, Itaru Omoto, Yasuto Uchikado, Yoshiaki Kita, Hiroshi Kurahara, Kosei Maemura, Shoji Natsugoe. Molecular pathogenesis of esophageal squamous cell carcinoma: Identification of the antitumor effects of miR‑145‑3p on gene regulation. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4657
|
| 18 |
Ya-Jun Luo, Qing-Mei Huang, Yan Ren, Zi-Lin Liu, Cheng-Fei Xu, Hao Wang, Jiang-Wei Xiao. Non-coding RNA in drug resistance of gastric cancer. World Journal of Gastrointestinal Oncology 2019; 11(11): 957-970 doi: 10.4251/wjgo.v11.i11.957
|
| 19 |
Jie Yang. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer. Medical Oncology 2020; 37(5) doi: 10.1007/s12032-020-01362-0
|
| 20 |
Shan Zhu, Ning Yang, Chao Niu, Wan Wang, Xue Wang, Junge Bai, Yuan Qiao, Shuanglin Deng, Yi Guan, Jingtao Chen. The miR-145–MMP1 axis is a critical regulator for imiquimod-induced cancer stemness and chemoresistance. Pharmacological Research 2022; 179: 106196 doi: 10.1016/j.phrs.2022.106196
|
| 21 |
Daniela B. Vera, Allison N. Fredes, Maritza P. Garrido, Carmen Romero. Role of Mitochondria in Interplay between NGF/TRKA, miR-145 and Possible Therapeutic Strategies for Epithelial Ovarian Cancer. Life 2021; 12(1): 8 doi: 10.3390/life12010008
|
| 22 |
Vitalba Ruggieri, Sabino Russi, Pietro Zoppoli, Francesco La Rocca, Tiziana Angrisano, Geppino Falco, Giovanni Calice, Simona Laurino. The Role of MicroRNAs in the Regulation of Gastric Cancer Stem Cells: A Meta-Analysis of the Current Status. Journal of Clinical Medicine 2019; 8(5): 639 doi: 10.3390/jcm8050639
|
| 23 |
Xiao Liang, Chang Xu, Wanchun Wang, Xiang Li. The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells. Stem Cells International 2019; 2019: 1 doi: 10.1155/2019/7028901
|
| 24 |
Si-Ning Shen, Ke Li, Ying Liu, Cheng-Liang Yang, Chun-Yu He, Hao-Rang Wang. RETRACTED: Silencing lncRNAs PVT1 Upregulates miR-145 and Confers Inhibitory Effects on Viability, Invasion, and Migration in EC. Molecular Therapy - Nucleic Acids 2020; 19: 668 doi: 10.1016/j.omtn.2019.11.030
|
| 25 |
Mohammad Roshani, Danial Molavizadeh, Sara Sadeghi, Ameneh Jafari, Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Sahar Ahmadi Asouri, Ali Rajabi, Michael R. Hamblin, Ali Arash Anoushirvani, Hamed Mirzaei. Emerging roles of miR-145 in gastrointestinal cancers: A new paradigm. Biomedicine & Pharmacotherapy 2023; 166: 115264 doi: 10.1016/j.biopha.2023.115264
|
| 26 |
Johannes Fänder, Heike Kielstein, Maximilian Büttner, Peter Koelblinger, Reinhard Dummer, Marcus Bauer, Diana Handke, Claudia Wickenhauser, Barbara Seliger, Simon Jasinski-Bergner. Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma. Oncotarget 2019; 10(60): 6509 doi: 10.18632/oncotarget.27305
|
| 27 |
Wenxiu Xu, Yuting Hua, Fei Deng, Dandan Wang, Yang Wu, Wei Zhang, Jinhai Tang. MiR‐145 in cancer therapy resistance and sensitivity: A comprehensive review. Cancer Science 2020; 111(9): 3122 doi: 10.1111/cas.14517
|
| 28 |
Mohammad Mahmoudi Gomari, Marziye Farsimadan, Neda Rostami, Zahra mahmoudi, Mahmood Fadaie, Ibrahim Farhani, Parastoo Tarighi. CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations. Mutation Research/Reviews in Mutation Research 2021; 787: 108374 doi: 10.1016/j.mrrev.2021.108374
|
| 29 |
Yue Ma, Yanyi Ren, Huitao Wen, Chengcheng Cui, Xiao-Jie Lu. circCOL1A1 Promotes the Progression of Gastric Cancer Cells through Sponging miR-145 to Enhance RABL3 Expression. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/6724854
|
| 30 |
Ren Wang, Hui‐Xing Dong, Jian Zeng, Jing Pan, Xiao‐Yan Jin. LncRNA DGCR5 contributes to CSC‐like properties via modulating miR‐330‐5p/CD44 in NSCLC. Journal of Cellular Physiology 2018; 233(9): 7447 doi: 10.1002/jcp.26590
|
| 31 |
Chao Chen, Xiaohuan Tang, Yuanda Liu, Jiaming Zhu, Jingjing Liu. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review). International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4751
|
| 32 |
Alireza Ahadi. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression. IUBMB Life 2020; 72(5): 884 doi: 10.1002/iub.2259
|
| 33 |
Si‐Ning Shen, Ke Li, Ying Liu, Cheng‐Liang Yang, Chun‐Yu He, Hao‐Rang Wang. Retracted: Down‐regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA‐145‐mediated inhibition of FSCN1. Molecular Oncology 2019; 13(12): 2554 doi: 10.1002/1878-0261.12555
|
| 34 |
Henu Kumar Verma, Yashwant Kumar Ratre, Pellegrino Mazzone, Simona Laurino, L. V. K. S. Bhaskar. Micro RNA facilitated chemoresistance in gastric cancer: a novel biomarkers and potential therapeutics. Alexandria Journal of Medicine 2020; 56(1): 81 doi: 10.1080/20905068.2020.1779992
|
| 35 |
Hyun Ah Seo, Sokviseth Moeng, Seokmin Sim, Hyo Jeong Kuh, Soo Young Choi, Jong Kook Park. MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies. Cells 2019; 9(1): 29 doi: 10.3390/cells9010029
|
| 36 |
Saba Tabasum, Monika Yadav. Post-Transcriptional Gene Regulation in Human Disease. 2022; : 119 doi: 10.1016/B978-0-323-91305-8.00011-9
|
| 37 |
Yiwen Wu, Xiaoyan Yang, Zhizhong Xie, Haihong Hu, Xiaoyong Lei, Dun Niu, Shiyan Li, Lu Tuo. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer. Combinatorial Chemistry & High Throughput Screening 2022; 25(13): 2127 doi: 10.2174/1386207325666220401090604
|
| 38 |
Fusheng Zhou, Weiqun Ding, Qiqi Mao, Xiaoyun Jiang, Jiajie Chen, Xianguang Zhao, Weijia Xu, Jiaxin Huang, Liang Zhong, Xu Sun. The regulation of hsacirc_004413 promotes proliferation and drug resistance of gastric cancer cells by acting as a competing endogenous RNA for miR-145-5p. PeerJ 2022; 10: e12629 doi: 10.7717/peerj.12629
|
| 39 |
Jianfeng Liu, Haiyue Li, Yuanwei Liu, Yao Sun, Jiamin Wu, Zichao Xiong, Bin Li, Tianbo Jin. MiR-143HG Gene Polymorphisms as Risk Factors for Gastric Cancer in Chinese Han Population. Current Molecular Medicine 2020; 20(7): 536 doi: 10.2174/1566524020666191227103144
|
| 40 |
Hanxiao Xu, Mengke Niu, Xun Yuan, Kongming Wu, Aiguo Liu. CD44 as a tumor biomarker and therapeutic target. Experimental Hematology & Oncology 2020; 9(1) doi: 10.1186/s40164-020-00192-0
|
| 41 |
Xionghui Rao, Chaojun Zhang, Huixing Luo, Jianbao Zhang, Zhehong Zhuang, Zhihao Liang, Xiaobin Wu. Targeting Gastric Cancer Stem Cells to Enhance Treatment Response. Cells 2022; 11(18): 2828 doi: 10.3390/cells11182828
|
| 42 |
Xue‑Feng Zhang, Xue‑Qi Zhang, Zhe‑Xing Chang, Cui‑Cui Wu, Hang Guo. microRNA‑145 modulates migration and invasion of bladder cancer cells by targeting N‑cadherin. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8910
|
| 43 |
Wei Feng, Zhangyao Su, Qingqing Yin, Wei Zong, Xianjuan Shen, Shaoqing Ju. ncRNAs associated with drug resistance and the therapy of digestive system neoplasms. Journal of Cellular Physiology 2019; 234(11): 19143 doi: 10.1002/jcp.28551
|
| 44 |
Jie Zhou, Xiyi Zhang, Weiling Li, Yuanyuan Chen. MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD4. Journal of Ovarian Research 2020; 13(1) doi: 10.1186/s13048-020-00656-1
|